Ticker Details
CASI Pharmaceuticals, Inc. CASI Pharmaceuticals Inc is engaged in research and development of biopharmaceutical products. It mainly focuses on acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs.
IPO Date:	July 1, 1996
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$4.26M
Activated in VL:	False

Average Daily Range
Avg Daily Range:	$0.10 | 3.93%
Avg Daily Range (30 D):	$0.04 | 8.49%
Avg Daily Range (90 D):	$0.04 | 4.69%

Institutional Daily Volume
Avg Daily Volume:	.12M
Avg Daily Volume (30 D):	.24M
Avg Daily Volume (90 D):	.1M

Trade Size
Avg Trade Size (Sh.):	99
Avg Trade Size (Sh.) (30 D):	353
Avg Trade Size (Sh.) (90 D):	295

Institutional Trades
Total Institutional Trades:	33
Avg Institutional Trade:	$1.88M
Avg Institutional Trade (30 D):	$2.95M
Avg Institutional Trade (90 D):	$2.95M
Avg Institutional Trade Volume:	.2M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.69M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$M
Avg Closing Volume:	94.73K

News

Jun 27, 2024 @ 1:42 PM CASI Pharmaceuticals (CASI) Up on Buyout Offer for... Source: Zacks Equity Research

Nov 15, 2023 @ 5:00 PM HC Wainwright & Co. Maintains Buy Rating for CASI ... Source: Benzinga Insights

Oct 24, 2023 @ 9:30 PM USANA Health Sciences (USNA) Q3 Earnings Miss Esti... Source: Zacks Equity Research

Oct 11, 2023 @ 12:24 PM Why VOXX International Shares Are Trading Higher B... Source: Lisa Levin

Aug 10, 2023 @ 2:04 PM Ionis Pharmaceuticals (IONS) Q2 Earnings and Reven... Source: Zacks Equity Research

Financials
	TTM	Q3 2022	Q2 2022
Basic EPS	$1.03	$-.38	$-.56
Diluted EPS	$1.03	$-.38	$-.56
Revenue	$37.01M	$10.21M	$8.57M
Gross Profit	$21.65M	$5.97M	$5.02M
Net Income / Loss	$-26.31M	$-5.02M	$-7.49M
Operating Income / Loss	$-32.76M	$-6.35M	$-7.75M
Cost of Revenue	$15.36M	$4.25M	$3.55M
Net Cash Flow	$-13.94M	$18.97M	$-9.52M
PE Ratio